Ideaya Biosciences Inc Logo

Ideaya Biosciences Inc (IDYA): Eigentümerstruktur

Takani Score ?
27.9

Preis (11.09.2026)52W Hoch52W Tief
37,59 US Dollar42,68 US Dollar24,238 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
52,385 US Dollar102100
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
96.489.48412,1613,81

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Ideaya Biosciences Inc
Mitarbeiter 145
Handelsplatz NASDAQ
Ticker Symbol IDYA
IPO Datum 2019-05-23
Adresse 5000 Shoreline Court, South San Francisco, CA, United States, 94080

Unternehmensführung

RangNamePosition
1Mr. Yujiro S. HataFounder, President, CEO & Chairman
2Dr. Joshua Bleharski M.B.A., Ph.D.Chief Financial Officer
3Mr. Andres Ruiz Briseno CPAChief Accounting Officer
4Dr. Michael A. White Ph.D.Chief Scientific Officer
5Mr. Douglas B. SnyderChief Legal Officer
6Dr. Darrin M. Beaupre M.D., Ph.D.Chief Medical Officer
7Dr. Paul A. Barsanti Ph.D.Chief Technology Officer
8Ms. Francine ZelayaSenior VP & Head of Human Resources
9Mr. Mick O'QuigleySenior Vice President of Medical Writing & Project Management
10Mr. Daniel A. SimonChief Business Officer

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1FMR Inc13,65%0,50 Mrd. USD
2BlackRock Inc8,75%0,32 Mrd. USD
3HHG PLC7,53%0,27 Mrd. USD
4Capital Research Global Investors5,54%0,20 Mrd. USD
5Baker Bros Advisors LP4,09%0,15 Mrd. USD
6State Street Corp3,92%0,14 Mrd. USD
7Vanguard Capital Management, LLC3,87%0,14 Mrd. USD
8Logos Global Management LP3,11%0,11 Mrd. USD
9Adage Capital Partners Gp LLC2,81%0,10 Mrd. USD
10Fiera Capital Corporation2,62%0,10 Mrd. USD
11Geode Capital Management, LLC2,59%0,09 Mrd. USD
12Morgan Stanley - Brokerage Accounts1,93%0,07 Mrd. USD
13Dimensional Fund Advisors, Inc.1,72%0,06 Mrd. USD
14The Goldman Sachs Group Inc1,72%0,06 Mrd. USD
15Deerfield Management Co1,59%0,06 Mrd. USD
16Federated Hermes Inc1,48%0,05 Mrd. USD
17GSK PLC1,38%0,05 Mrd. USD
18T. Rowe Price Associates, Inc.1,36%0,05 Mrd. USD
19Sofinnova Ventures1,17%0,04 Mrd. USD
20Candriam Luxembourg S.C.A.1,15%0,04 Mrd. USD